These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 8760420)

  • 21. [The modelling of a persistent parainfluenza infection].
    Ukbaeva TD; Karal'nik BV; Ismagulov AT
    Vopr Virusol; 1991; 36(5):387-9. PubMed ID: 1666475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA.
    Zhao H; De BP; Das T; Banerjee AK
    Virology; 1996 Jun; 220(2):330-8. PubMed ID: 8661384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody and complement-mediated cytotoxicity for bovine parainfluenza-3 virus-infected cells.
    Hussain A; Mohanty SB
    Am J Vet Res; 1984 Jun; 45(6):1219-21. PubMed ID: 6331235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nasal secretion and serum antibody response of lambs following vaccination and aerosol challenge with parainfluenza 3 virus.
    Smith WD
    Res Vet Sci; 1975 Jul; 19(1):56-62. PubMed ID: 168628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution to the study of the parainfluenza antigens.
    Bosshard S; Aymard M; Kessler N
    Dev Biol Stand; 1975; 28():18-27. PubMed ID: 165116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutations within the human parainfluenza virus type 3 (HPIV 3) C protein affect viral replication and host interferon induction.
    Wells G; Addington-Hall M; Malur AG
    Virus Res; 2012 Aug; 167(2):385-90. PubMed ID: 22634035
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein.
    Brideau RJ; Oien NL; Lehman DJ; Homa FL; Wathen MW
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():471-7. PubMed ID: 8383179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunity against parainfluenza-3 virus in cattle; immunoglobulins in serum and nasal secretions after subcutaneous and nasal vaccination.
    Morein B
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jul; 144(1):63-74. PubMed ID: 4377636
    [No Abstract]   [Full Text] [Related]  

  • 29. Parainfluenza virus type 3 (PIV3)-specific and non-virus-specific delayed type hypersensitivity responses in cotton rats given different PIV3 antigen preparations.
    Ambrose MW; Wyde PR
    Vaccine; 1993; 11(3):336-42. PubMed ID: 8383384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of trivalent inactivated influenza vaccines in the cotton rat Sigmodon hispidus model.
    Yim K; Miles B; Zinsou R; Prince G; Boukhvalova M
    Vaccine; 2012 Feb; 30(7):1291-6. PubMed ID: 22210139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isogenic adenoviruses type 5 expressing or not expressing the E1A gene: efficiency as virus vectors in the vaccination of permissive and non-permissive species.
    Eloit M; Adam M
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1583-9. PubMed ID: 9049365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo.
    Moscona A; Porotto M; Palmer S; Tai C; Aschenbrenner L; Triana-Baltzer G; Li QX; Wurtman D; Niewiesk S; Fang F
    J Infect Dis; 2010 Jul; 202(2):234-41. PubMed ID: 20533871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies.
    Durbin AP; Cho CJ; Elkins WR; Wyatt LS; Moss B; Murphy BR
    J Infect Dis; 1999 Jun; 179(6):1345-51. PubMed ID: 10228053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meaning of circulating antibody titers in the infections of parainfluenza 3 virus and RS virus.
    Fukumi H
    Dev Biol Stand; 1975; 28():159-66. PubMed ID: 165115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rabbit model for mucosal immunity in the bowel. II. Local cellular reactivity to virus infection.
    Ramsay AJ; Holmes MJ
    Immunology; 1990 Jan; 69(1):27-32. PubMed ID: 2155872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of bovine herpesvirus-1 or parainfluenza-3 virus on immune receptor-mediated functions of bovine alveolar macrophages in the presence or absence of virus-specific serum or pulmonary lavage fluids collected after virus infection.
    Brown TT; Shin K
    Am J Vet Res; 1990 Oct; 51(10):1616-22. PubMed ID: 2173445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure of calves to aerosols of parainfluenza-3 virus and Pasteurella haemolytica.
    Carrière PD; Maxie MG; Wilkie BN; Savan M; Valli VE; Johnson JA
    Can J Comp Med; 1983 Oct; 47(4):422-32. PubMed ID: 6320999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-viral cytotoxic lymphocyte response in hamsters with parainfluenza virus type 3 infection.
    Henderson FW
    Adv Exp Med Biol; 1981; 134():215-9. PubMed ID: 6261540
    [No Abstract]   [Full Text] [Related]  

  • 39. [The antiviral activity of deitiforin in experimental para-influenza infection].
    Boldasov VK; Kalinina NA; Revunova OV; Guseva VM; Leonov VM; Sukhinin VP; Il'enko VI
    Vopr Virusol; 1991; 36(5):389-92. PubMed ID: 1666476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of proteolysis inhibitors for treating parainfluenza infections in an experiment and in the clinic].
    Bukrinskaia AG; Ketiladze ES; Sharova NK; Kornilaeva GV; Ustina VP
    Vopr Virusol; 1986; 31(4):400-4. PubMed ID: 3020805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.